Shaping the Future of Drug Delivery!

On 10–11 December, the NAP4DIVE consortium gathered in Gothenburg, hosted by AstraZeneca, to accelerate innovation in nanoparticle-based drug delivery and ethical research.


Highlights from the meeting:

◾ Progress on the Nanoparticle (NP) design library and digital design simulator
◾Development of decision-making tools to select NPs for next-step validation
◾Updates on flow conditions using the AKITA plate
◾Definition of a scenario library for possible outcomes, integrating ethical aspects and decision-tree modeling
◾Establishing collaboration with our Ethics Board

The meeting featured:

▪️ Dynamic workshops on ethical scenarios led by TU/e
▪️Valuable feedback from our Ethics Board and External Advisory Board
▪️A visit to AstraZeneca’s cutting-edge laboratories
▪️Networking and enjoying Gothenburg’s culinary highlights

These discussions mark an important step toward innovative, ethical, and standardized approaches in nanoparticle-based drug delivery.